These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11754690)

  • 1. From the Food and Drug Administration.
    Schwetz BA
    JAMA; 2002 Jan; 287(1):33. PubMed ID: 11754690
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of rheumatoid arthritis with interleukin 1 receptor antagonist.
    Bresnihan B
    Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I96-8. PubMed ID: 10577983
    [No Abstract]   [Full Text] [Related]  

  • 3. The trials of anakinra.
    Burls A; Jobanputra P
    Lancet; 2004 Sep 4-10; 364(9437):827-8. PubMed ID: 15351176
    [No Abstract]   [Full Text] [Related]  

  • 4. Anakinra shows promise for treating patients with rheumatoid arthritis.
    McIntosh T; Freeman TR
    J Am Pharm Assoc (Wash); 2002; 42(4):660-2. PubMed ID: 12150367
    [No Abstract]   [Full Text] [Related]  

  • 5. The many worlds of reducing interleukin-1.
    Dinarello CA
    Arthritis Rheum; 2005 Jul; 52(7):1960-7. PubMed ID: 15986340
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of anakinra on clinical and radiological outcomes in rheumatoid arthritis.
    Bresnihan B
    Ann Rheum Dis; 2002 Nov; 61 Suppl 2(Suppl 2):ii74-7. PubMed ID: 12379629
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of interleukin-1 blockade on fatigue in rheumatoid arthritis--a pilot study.
    Omdal R; Gunnarsson R
    Rheumatol Int; 2005 Aug; 25(6):481-4. PubMed ID: 15071755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anakinra for therapy of rheumatoid arthritis].
    Tomoo T; Sumida T
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():534-7. PubMed ID: 15799413
    [No Abstract]   [Full Text] [Related]  

  • 9. [Interleukin-1 inhibitors: a new alternative for the treatment of rheumatoid polyarthritis].
    Gabay C
    Rev Med Suisse Romande; 2000 Jun; 120(6):529-33. PubMed ID: 11014098
    [No Abstract]   [Full Text] [Related]  

  • 10. Bringing the clinical experience with anakinra to the patient.
    Cohen SB; Rubbert A
    Rheumatology (Oxford); 2003 May; 42 Suppl 2():ii36-40. PubMed ID: 12817094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine blocker licensed for relief of rheumatoid arthritis symptoms.
    Am J Health Syst Pharm; 2002 Feb; 59(3):225-6. PubMed ID: 11862629
    [No Abstract]   [Full Text] [Related]  

  • 12. Using anakinra for adult rheumatoid arthritis.
    Kastanek L
    Nurse Pract; 2002 Apr; 27(4):62-5. PubMed ID: 11984420
    [No Abstract]   [Full Text] [Related]  

  • 13. Effective use of the recombinant interleukin 1 receptor antagonist anakinra in therapy resistant systemic onset juvenile rheumatoid arthritis.
    Verbsky JW; White AJ
    J Rheumatol; 2004 Oct; 31(10):2071-5. PubMed ID: 15468378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interleukin-1 receptor antagonists in the treatment rheumatoid arthritis].
    Zoń-Giebel A; Kotulska A; Giebel S; Cader SA; Kucharz EJ
    Przegl Lek; 2002; 59(11):916-8. PubMed ID: 12715722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and radiological effects of anakinra in patients with rheumatoid arthritis.
    Bresnihan B; Cobby M
    Rheumatology (Oxford); 2003 May; 42 Suppl 2():ii22-8. PubMed ID: 12817092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated protein C for severe sepsis.
    Ely EW; Bernard GR; Vincent JL
    N Engl J Med; 2002 Sep; 347(13):1035-6. PubMed ID: 12324564
    [No Abstract]   [Full Text] [Related]  

  • 17. [The FDA's questions].
    Opal S
    Ann Fr Anesth Reanim; 2003 Dec; 22 Spec No 1():20-2. PubMed ID: 15359935
    [No Abstract]   [Full Text] [Related]  

  • 18. [Glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis and collagen diseases].
    Sohen S
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():673-6. PubMed ID: 15035207
    [No Abstract]   [Full Text] [Related]  

  • 19. [Kineret, Enbrel, Remicade and company. Recombinant drugs in rheumatoid arthritis].
    Zündorf I; Dingermann T
    Pharm Unserer Zeit; 2003; 32(5):376-83. PubMed ID: 14526457
    [No Abstract]   [Full Text] [Related]  

  • 20. [When are "biologics" indicated?].
    MMW Fortschr Med; 2006 Apr; 148(17):10. PubMed ID: 16711479
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.